Evaluation of MCM-2 expression in TMA cervical specimens

Area of Science:

• Oncology
• Cell Biology
• Immunohistochemistry

Background:

• Minichromosome maintenance proteins (MCM) are crucial for DNA replication and are highly expressed in proliferating cells.
• Cervical carcinoma and its precursor lesions require reliable biological markers for early detection and diagnosis.
• MCM-2 is investigated as a potential biomarker in cervical dysplasia.

Purpose of the Study:

• To evaluate the immunohistochemical expression of MCM-2 in HIV-positive and HIV-negative women with cervical dysplasia.
• To determine the diagnostic utility of MCM-2 for high-grade cervical intraepithelial neoplasia (CIN) and invasive cervical cancer.

Main Methods:

• Immunohistochemical analysis of MCM-2 expression in 352 cervical tissue specimens (normal, low-grade CIN, high-grade CIN, invasive cancer).
• Inclusion of 38 specimens from HIV-positive women.
• Receiver operating characteristic (ROC) curve analysis to establish diagnostic cutoffs.

Main Results:

• Significant differences in MCM-2 expression were observed across the spectrum from normal epithelium to high-grade CIN and invasive cancer (p<0.05).
• ROC analysis (AUC 0.78) indicated MCM-2 sensitivity of 81%, specificity of 66% for diagnosing high-grade CIN/cancer.
• HIV-positive specimens showed significantly lower MCM-2 expression in low-grade CIN and high-grade CIN compared to HIV-negative specimens (p<0.0001).

Conclusions:

• Immunohistochemical MCM-2 expression may not be a sufficiently sensitive or specific biomarker for diagnosing high-grade CIN and invasive cervical cancer.
• MCM-2 expression is notably reduced in dysplastic cervical lesions of HIV-positive individuals, suggesting potential differences in disease progression or marker behavior within this population.